Amgen (AMGN) Times Interest Earned (2009 - 2026)
Amgen (AMGN) posted quarterly Times Interest Earned of $4.06 for Q1 2026, up 149.05% year-over-year from $1.63 in Q1 2025, and down 2.58% on a QoQ basis from $4.17 in Q4 2025.
Amgen (AMGN) Times Interest Earned (2009 - 2026) Analysis & Trends
Amgen (AMGN) has reported Times Interest Earned for 18 consecutive years, with $4.06 the latest figure, recorded in Q1 2026.
- In Q1 2026, Times Interest Earned rose 149.05% year-over-year to $4.06; the TTM figure through Mar 2026 stood at $3.93 (up 61.22% YoY), while the FY2025 annual figure was $3.3, up 43.27% from the prior year.
- Times Interest Earned came in at $4.06 for Q1 2026 at Amgen, down from $4.17 in the prior quarter.
- The five-year high for Times Interest Earned was $8.47 in Q1 2022, with the low at $1.2 in Q1 2024.
- Average Times Interest Earned over 5 years is $3.86, with a median of $3.57 recorded in 2023.
- Across the five-year window, Times Interest Earned sank 71.19% in 2023 and soared 149.05% in 2026, its largest moves.
- Year by year, Times Interest Earned stood at $5.37 in 2022, then tumbled by 71.19% to $1.55 in 2023, then jumped by 99.84% to $3.09 in 2024, then surged by 34.64% to $4.17 in 2025, then dropped by 2.58% to $4.06 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered $4.06, $4.17, and $3.69 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 23.39 |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -10.80 |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 4.06 |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 10.78 |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.06 |
| Dec 31, 2025 | 4.17 |
| Sep 30, 2025 | 3.69 |
| Jun 30, 2025 | 3.83 |
| Mar 31, 2025 | 1.63 |
| Dec 31, 2024 | 3.09 |
| Sep 30, 2024 | 2.64 |
| Jun 30, 2024 | 2.36 |
| Mar 31, 2024 | 1.20 |
| Dec 31, 2023 | 1.55 |
| Sep 30, 2023 | 2.66 |
| Jun 30, 2023 | 3.57 |
| Mar 31, 2023 | 3.54 |
| Dec 31, 2022 | 5.37 |
| Sep 30, 2022 | 7.23 |
| Jun 30, 2022 | 6.63 |
| Mar 31, 2022 | 8.47 |
| Dec 31, 2021 | 6.88 |
| Sep 30, 2021 | 8.03 |
| Jun 30, 2021 | 2.95 |